Long-term toxicity and survival outcomes after stereotactic ablative radiotherapy for patients with centrally located thoracic tumors

Atalar, BANU; Mustafayev, TZ; Sio, TT; Sahin, B; Gungor, GORKEM; Aydın, GOKHAN; Yapici, BULENT; Ozyar, ENİS

doi:10.2478/raon-2020-0039

Long-term toxicity and survival outcomes after stereotactic ablative radiotherapy for patients with centrally located thoracic tumors

Atalar B., Mustafayev T., Sio T., Sahin B., Gungor G., Aydın G., ...Daha Fazla

Radiology and Oncology, cilt.54, sa.4, ss.480-487, 2020 (SCI-Expanded, Scopus)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 54 Sayı: 4
Basım Tarihi: 2020
Doi Numarası: 10.2478/raon-2020-0039
Dergi Adı: Radiology and Oncology
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Agricultural & Environmental Science Database, CINAHL, EMBASE, MEDLINE, Directory of Open Access Journals
Sayfa Sayıları: ss.480-487
Anahtar Kelimeler: lung cancer, radiation, stereotactic ablative radiotherapy, stereotactic body radiation therapy, survival outcomes, toxicity, BODY RADIATION-THERAPY, CELL LUNG-CANCER, EARLY-STAGE, PHASE-II
Açık Arşiv Koleksiyonu: AVESİS Açık Erişim Koleksiyonu
Acıbadem Mehmet Ali Aydınlar Üniversitesi Adresli: Evet

Özet

Background. Stereotactic ablative radiotherapy (SABR) is effective for thoracic cancer and metastases; however, adverse effects are greater for central tumors. We evaluated factors affecting outcomes and toxicities after SABR for patients with primary lung and oligometastatic tumors.